… The results of the present study suggest that preoperative administration of ticagrelor with
or without aspirin compared with aspirin alone did not affect in-hospital death, major bleeding …

… -aspirin (n = 20) and on aspirin alone and on dual antiplatelet therapy comprising aspirin plus
clopidogrel (n = 20), ticagrelor (n … Whilst clopidogrel had no effect, ticagrelor and cangrelor …

… aspirin compared with aspirin alone in patients with stable CAD.29 In contrast, the Apixaban
Plus Mono versus Dual Antiplatelet Therapy in Acute Coronary Syndromes Trial found no …

… This study aims to compare the impact of aspirin (ASA) monotherapy, P2Y12 monotherapy,
and DAPT on limb salvage (LS), amputation-free survival (AFS), and overall survival (OS) in …

… inhibition of P2Y 12 was evident with VN-P2Y12. There was strong correlation with VN-P2Y12
and … At high levels of P2Y 12 inhibition, platelet function measured by VN-P2Y12 was …

… Aspirin and the thienopyridines each significantly reduce … aspirin than with aspirin alone,
5,7,8 a finding consistent with the drugs' complementary mechanisms of action. Aspirin inhibits …

… aspirin Clopidogrel, prasugrel, or ticagrelor plus aspirin Clopidogrel or prasugrel plus aspirin
Ticagrelor plus aspirin Ticagrelor plus aspirin … followed by P2Y12 inhibitor monotherapy vs. …

… atherosclerotic outpatients on treatment with aspirin 75 to 100 mg once daily received
ticagrelor (50, 100, or 200 mg BID or 400 mg QD) or clopidogrel 75 mg once daily for 28 days. …

… Dual antiplatelet therapy (DAPT), the combination of aspirin and a P2Y12 inhibitor, given
for 12 months remains the standard of care after presentation with acute coronary syndrome (…

… of stopping aspirin in patients treated with vorapaxar and a newer‐generation P2Y 12 inhibitor
is … ‐generation P2Y 12 inhibitor (prasugrel or ticagrelor) with and without aspirin in a real‐…